Margo J. H. van Campenhout

Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment

Margo J. H. van Campenhout, Florian van Bömmel, Maria Pfefferkorn et al. · Hepatology · 2018 · 88 citations · Full text

Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B

Mina Farag, Margo J. H. van Campenhout, Maria Pfefferkorn et al. · Clinical Infectious Diseases · 2020 · 69 citations · Full text

Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B

Kin Seng Liem, Margo J. H. van Campenhout, Qing Xie et al. · Alimentary Pharmacology & Therapeutics · 2019 · 31 citations · Full text

Ultra-Long-term Follow-up of Interferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B Virus Infection

Hannah Choi, Margo J. H. van Campenhout, Anneke J. van Vuuren et al. · Clinical Gastroenterology and Hepatology · 2020 · 30 citations

Viral Persistence, Hepatology, Viral Hepatitis +9

Hepatitis B core-related antigen levels are associated with response to entecavir and peginterferon add-on therapy in hepatitis B e antigen–positive chronic hepatitis B patients

Margo J. H. van Campenhout, Willem Pieter Brouwer, Gertine W. van Oord et al. · Clinical Microbiology and Infection · 2016 · 28 citations

Hepatic Disorders, Autoimmune Disease, Hepatology +9